November 12, 2026: Think Tank on Advancing Precision Medicine in Rare Cancers Learn more and register.×

Dr Brian Alexander, CEO of Foundation Medicine, discusses the role of serial blood testing in TRACK.

Dr. Brian Alexander, CEO of Foundation Medicine, speaks about the importance of serial blood testing in the TRACK Study, as well as its unique importance in rare cancers.